Morbidity Associated With Primary Hyperparathyroidism-A Population-based Study With a Subanalysis on Vitamin D

Area of Science:

• Endocrinology
• Public Health
• Clinical Epidemiology

Background:

• Primary hyperparathyroidism (PHPT) is linked to increased morbidity and mortality.
• Vitamin D levels may confound the observed risks associated with PHPT.

Purpose of the Study:

• To assess the association between primary hyperparathyroidism (PHPT) and clinical outcomes, including morbidity and mortality.
• To determine if these associations are independent of serum vitamin D concentrations.

Main Methods:

• A population-based, retrospective, matched cohort study was conducted in Tayside, Scotland (1997-2019).
• Data linkage included biochemistry, hospital admissions, prescribing, imaging, pathology, and death records.
• Cox proportional hazards models were used to analyze outcomes in patients with PHPT compared to a matched cohort.

Main Results:

• The study included 11,616 individuals with PHPT.
• PHPT was associated with a 2.05-fold increased risk of death.
• Increased risks for diabetes (HR=1.39), renal stones (HR=3.02), and osteoporosis (HR=1.31) persisted after adjusting for vitamin D levels.

Conclusions:

• Primary hyperparathyroidism (PHPT) is independently associated with increased mortality, diabetes, renal stones, and osteoporosis.
• These risks are evident irrespective of serum vitamin D concentrations.
• The findings highlight the significant long-term health implications of untreated PHPT.